Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20381 | 401 | 40.0 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROHIBITIN | Author keyword | 140 | 69% | 30% | 120 |
2 | PROHIBITIN 1 | Author keyword | 6 | 71% | 1% | 5 |
3 | BRE | Author keyword | 6 | 53% | 2% | 8 |
4 | BAP37 | Author keyword | 6 | 100% | 1% | 4 |
5 | PROHIBITINS | Author keyword | 4 | 67% | 1% | 4 |
6 | BRE GENE | Author keyword | 3 | 100% | 1% | 3 |
7 | HYPERSENSITIVE INDUCED REACTION PROTEIN | Author keyword | 3 | 100% | 1% | 3 |
8 | PROHIBITIN 2 | Author keyword | 3 | 60% | 1% | 3 |
9 | PROHIBITIN PHB | Author keyword | 2 | 67% | 0% | 2 |
10 | RVP1 | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROHIBITIN | 140 | 69% | 30% | 120 | Search PROHIBITIN | Search PROHIBITIN |
2 | PROHIBITIN 1 | 6 | 71% | 1% | 5 | Search PROHIBITIN+1 | Search PROHIBITIN+1 |
3 | BRE | 6 | 53% | 2% | 8 | Search BRE | Search BRE |
4 | BAP37 | 6 | 100% | 1% | 4 | Search BAP37 | Search BAP37 |
5 | PROHIBITINS | 4 | 67% | 1% | 4 | Search PROHIBITINS | Search PROHIBITINS |
6 | BRE GENE | 3 | 100% | 1% | 3 | Search BRE+GENE | Search BRE+GENE |
7 | HYPERSENSITIVE INDUCED REACTION PROTEIN | 3 | 100% | 1% | 3 | Search HYPERSENSITIVE+INDUCED+REACTION+PROTEIN | Search HYPERSENSITIVE+INDUCED+REACTION+PROTEIN |
8 | PROHIBITIN 2 | 3 | 60% | 1% | 3 | Search PROHIBITIN+2 | Search PROHIBITIN+2 |
9 | PROHIBITIN PHB | 2 | 67% | 0% | 2 | Search PROHIBITIN+PHB | Search PROHIBITIN+PHB |
10 | RVP1 | 2 | 67% | 0% | 2 | Search RVP1 | Search RVP1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CRISTAE MORPHOGENESIS | 17 | 52% | 6% | 23 |
2 | PROHIBITIN | 10 | 27% | 7% | 30 |
3 | SPFH DOMAIN | 7 | 35% | 4% | 17 |
4 | ANTIPROLIFERATIVE PROTEIN | 6 | 80% | 1% | 4 |
5 | STOMATINS | 6 | 71% | 1% | 5 |
6 | STRESS MODULATING GENE | 6 | 100% | 1% | 4 |
7 | ESTROGEN RECEPTOR ACTIVITY | 5 | 32% | 3% | 13 |
8 | ACTIVITY REA | 3 | 57% | 1% | 4 |
9 | CAHIR1 | 3 | 100% | 1% | 3 |
10 | MITOCHONDRIAL PROTEINS | 3 | 13% | 6% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Prohibitins Role in Cellular Survival Through Ras-Raf-MEK-Erk Pathway | 2014 | 10 | 98 | 71% |
Signaling pathways of prohibitin and its role in diseases | 2013 | 14 | 116 | 83% |
The role and therapeutic potential of prohibitin in disease | 2011 | 55 | 85 | 61% |
Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential | 2013 | 19 | 159 | 48% |
The prohibitins: emerging roles in diverse functions | 2006 | 146 | 53 | 75% |
Prohibitin: a potential target for new therapeutics | 2005 | 133 | 41 | 76% |
Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis | 2009 | 143 | 88 | 41% |
The role of prohibitin in cell signaling | 2010 | 60 | 64 | 44% |
Prohibitin 2: At a communications crossroads | 2015 | 1 | 69 | 39% |
Prohibitin and mitochondrial biology | 2009 | 87 | 79 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COOPERAT REPROD SCI | 1 | 19% | 1.2% | 5 |
2 | HEPAT BILIARY PANCREAT VASC SURG | 1 | 40% | 0.5% | 2 |
3 | CLUSTER OFF CSS 633 | 1 | 50% | 0.2% | 1 |
4 | COMPREHENS CANC INTERNAL MED | 1 | 50% | 0.2% | 1 |
5 | COOPERAT BIOSCI CIC BIOGUNE | 1 | 50% | 0.2% | 1 |
6 | HARRIS PROSTATE CANC | 1 | 50% | 0.2% | 1 |
7 | LEGAL MED MED ETH SOCIAL OCCUPAT MED | 1 | 50% | 0.2% | 1 |
8 | MOL GENOME ANAL MOL GENET BREAST CANC | 1 | 50% | 0.2% | 1 |
9 | NIJMEGEN MITOCHONDRIAL METAB DISORDERS | 1 | 50% | 0.2% | 1 |
10 | S REGENERAT MED | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000139252 | STOMATIN//PSEUDOHYPERKALAEMIA//REGGIE |
2 | 0.0000123432 | MAZUMDAR SHAW TRANSLAT//2 DIMENSIONAL LIQUID CHROMATOGRAPHY//BIOLOGICAL VARIATION ANALYSIS |
3 | 0.0000087965 | UNITE BIOTECHNOL BIOINGN//RECHUNITE BIOTECHNOL BIOINGN//COLCHICINE BINDING SITE LIGANDS |
4 | 0.0000087540 | PBK TOPK//PDZ BINDING KINASE//PBK |
5 | 0.0000076572 | ZETA CRYSTALLIN//CAMEL LENS//PIG3 |
6 | 0.0000072540 | CALUMENIN//BIOCHEM FUNCT PROTE//RETICULOCALBIN |
7 | 0.0000064097 | LEUCINE RICH ALPHA 2 GLYCOPROTEIN 1//GLOBAL OLARS PROGRAM//LRG1 |
8 | 0.0000052408 | ANGIOTENSIN CONVERTING ENZYME 1//ANTI THY11//KNOWLEDGE TRANSFER TRANSLATION |
9 | 0.0000043732 | MITOCHONDRIAL FISSION//MITOCHONDRIAL DYNAMICS//DRP1 |
10 | 0.0000042915 | GRP METAB ENERGET NUTR//SKELETAL MUSCLE PROTEOMICS//MUSCLE PROTEOMICS |